Menu
Back to User profile » Dr Xiangkun Wang
Papers published by Dr Xiangkun Wang:
RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma
Wei Y, Lan C, Wang X, Zhou X, Liao X, Huang H, Wei Z, Li T, Peng T, Zhu G
International Journal of General Medicine 2023, 16:4377-4392
Published Date: 26 September 2023
Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Hepatectomy
Huang H, Liao X, Zhu G, Han C, Wang X, Yang C, Zhou X, Liang T, Huang K, Peng T
Pharmacogenomics and Personalized Medicine 2022, 15:277-300
Published Date: 29 March 2022
The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma
Ruan GT, Gong YZ, Zhu LC, Gao F, Liao XW, Wang XK, Zhu GZ, Liao C, Wang S, Yan L, Xie HL, Zhou X, Liu JQ, Shao MN, Gan JL
OncoTargets and Therapy 2020, 13:9389-9405
Published Date: 23 September 2020
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy
Liao X, Han C, Wang X, Huang K, Yu T, Yang C, Huang R, Liu Z, Han Q, Peng T
Cancer Management and Research 2018, 10:3255-3271
Published Date: 5 September 2018
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Liao X, Wang X, Huang K, Yang C, Yu T, Han C, Zhu G, Su H, Huang R, Peng T
Cancer Management and Research 2018, 10:2537-2551
Published Date: 10 August 2018
The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma
Yu T, Wang X, Zhu G, Han C, Su H, Liao X, Yang C, Qin W, Huang K, Peng T
Cancer Management and Research 2018, 10:1713-1726
Published Date: 25 June 2018
Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population
Ye X, Wang X, Shang L, Zhu G, Su H, Han C, Qin W, Li G, Peng T
Cancer Management and Research 2018, 10:1037-1050
Published Date: 4 May 2018
Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma
Liao X, Zhu G, Huang R, Yang C, Wang X, Huang K, Yu T, Han C, Su H, Peng T
Cancer Management and Research 2018, 10:787-803
Published Date: 13 April 2018
Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma
Yang C, Su H, Liao X, Han C, Yu T, Zhu G, Wang X, Winkler CA, O'Brien SJ, Peng T
Cancer Management and Research 2018, 10:679-696
Published Date: 10 April 2018
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Liao X, Huang K, Huang R, Liu X, Han C, Yu L, Yu T, Yang C, Wang X, Peng T
OncoTargets and Therapy 2017, 10:4493-4506
Published Date: 12 September 2017